Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Curaleaf Introduces New Medical Cannabis Products

Curaleaf
Posted on: 10 Oct 17

PR Newswire

MIAMI, Oct. 10, 2017

MIAMI, Oct. 10, 2017 /PRNewswire/ -- In continuing to deliver on its mission to provide access to the highest standards of safe, consistent and reliable medical cannabis products, Curaleaf announced today several new products are available at its Dadeland area dispensary and for delivery to Florida's qualified patients. Products include vaporizer pens in single Indica and Sativa THC strains and THC concentrates made from pure THC distillate.

"At Curaleaf, we develop medical cannabis products using the industry's cleanest, most medically precise extraction and purification methods," said Gregg Roberts, Chief Executive Officer, Curaleaf. "Recent research and feedback from local physicians indicate that THC medical cannabis concentrate products have shown positive results in providing patients suffering from conditions such as cancer or chronic pain with immediate relief. It is our commitment to Florida's patients to continue developing and providing accessibility to exceptional quality products that deliver natural relief."

Located at 9002 Dadeland Boulevard, Unit 1, Curaleaf is open Monday through Friday, 10am to 7pm and Saturday, 10am to 5pm, and provides free valet parking to all patients. The State of Florida's Office of Medical Marijuana Use Registry requires an order from a qualified Florida ordering physician and a State of Florida medical marijuana card to obtain medical cannabis products. In addition, Curaleaf will continue to offer patients free delivery in Miami-Dade, Broward, Palm Beach, Lee, Collier and Monroe counties in an effort to support and provide patients who may have been affected by Hurricane Irma with access to the medicine they need.  Discount programs are in effect for Breast Cancer Awareness Month, pediatric patients, military veterans, and government financial assistance patients. 

About Curaleaf
Led by a team of physicians, pharmacists, medical experts and industry visionaries, Curaleaf develops safe, effective, and innovative cannabis-based therapeutic products. Curaleaf combines the industry's most medically precise and technologically advanced production techniques with decades of horticultural experience, to ensure consistently exceptional quality that patients and health care professionals can trust. Based on a foundation of compassion, professionalism and respect, Curaleaf strives to empower physicians and patients by helping them make the right choices, as the industry's leading resource in product expertise, education, and through their commitment to advancement through research and advocacy. More information regarding Curaleaf can be found at www.curaleaf.com.

View original content with multimedia:http://www.prnewswire.com/news-releases/curaleaf-introduces-new-medical-cannabis-products-300533562.html

SOURCE Curaleaf

PR Newswire
www.prnewswire.com

Last updated on: 10/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.